{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:56:20Z","timestamp":1774331780981,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["AGL2016-79813-C2-1R"],"award-info":[{"award-number":["AGL2016-79813-C2-1R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2017-83575-R"],"award-info":[{"award-number":["SAF2017-83575-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["CTQ2015-67871-R"],"award-info":[{"award-number":["CTQ2015-67871-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gobierno Vasco","award":["IT 992-16"],"award-info":[{"award-number":["IT 992-16"]}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UE","award":["LE020P17"],"award-info":[{"award-number":["LE020P17"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejmech.2018.04.033","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T06:33:47Z","timestamp":1524033227000},"page":"137-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation"],"prefix":"10.1016","volume":"152","author":[{"given":"Ana","family":"Tejer\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"P\u00e9rez-Pertejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa M.","family":"Reguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Bala\u00f1a-Fouce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0866-3493","authenticated-orcid":false,"given":"Concepci\u00f3n","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Rubiales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.04.033_sref1","unstructured":"(For reviews see: )"},{"key":"10.1016\/j.ejmech.2018.04.033_bib1a","first-page":"26","article-title":"Limitations of current therapeutic options, possible drug targets and scope of natural products in control of leishmaniasis","volume":"18","author":"Tiwari","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib1b","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3\u20134","author":"Sundar","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.04.033_bib1c","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"Sundar","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2018.04.033_bib1d","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy-challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2018.04.033_sref2","unstructured":"(For reviews see: )"},{"key":"10.1016\/j.ejmech.2018.04.033_bib2a","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/08982104.2017.1376682","article-title":"Liposomal formulations in the pharmacological treatment of leishmaniasis: a review","volume":"27","author":"Ortega","year":"2017","journal-title":"J.\u00a0Liposome Res."},{"key":"10.1016\/j.ejmech.2018.04.033_bib2b","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/1381612822666161027103640","article-title":"Exploring the role of nanoparticles in amphotericin B delivery","volume":"23","author":"Zaioncz","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2018.04.033_bib2c","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/QCO.0b013e328359eff2","article-title":"Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis","volume":"25","author":"Mohamed-Ahmed","year":"2012","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.04.033_bib2d","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.qco.0000191508.48481.f4","article-title":"Comparison of the efficacy and pharmacology of formulations of amphotericin B used in treatment of leishmaniasis","volume":"18","author":"Barratt","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.04.033_bib3a","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/cid\/civ004","article-title":"Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations","volume":"60","author":"Monge-Maillo","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.04.033_bib3b","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2018.04.033_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijpddr.2014.05.001","article-title":"Target-based vs. phenotypic screenings in Leishmania drug discovery: a marriage of convenience or a dialogue of the deaf?","volume":"4","author":"Reguera","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2018.04.033_bib5a","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/cb300648v","article-title":"Drugging topoisomerases: lessons and challenges","volume":"8","author":"Pommier","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.04.033_bib5b","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.04.033_bib5c","first-page":"1512","article-title":"DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damage","volume":"3","author":"Nitiss","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2018.04.033_bib5d","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1517\/13543776.2013.790958","article-title":"Topoisomerase inhibitors as anticancer agents: a patent update","volume":"23","author":"Khadka","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.04.033_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpddr.2014.07.006","article-title":"Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery","volume":"4","author":"Bala\u00f1a-Fouce","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2018.04.033_bib7a","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1074\/jbc.M203991200","article-title":"A\u00a0novel active DNA topoisomerase I in Leishmania donovani","volume":"278","author":"Villa","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib7b","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.febslet.2004.03.078","article-title":"Reconstitution and functional characterization of the unusual bi-subunit type I DNA topoisomerase from Leishmania donovani","volume":"565","author":"Das","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2018.04.033_bib8a","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.biochi.2007.07.015","article-title":"Structural insights on the small subunit of DNA topoisomerase I from the unicellular parasite Leishmania donovani","volume":"89","author":"D\u00edaz Gonz\u00e1lez","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2018.04.033_bib8b","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001177","article-title":"Deletion study of DNA topoisomerase IB from Leishmania donovani: searching for a minimal functional heterodimer","volume":"2","author":"D\u00edaz Gonz\u00e1lez","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.04.033_sref5","unstructured":"(For reviews see: )"},{"key":"10.1016\/j.ejmech.2018.04.033_bib9a","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1016\/j.bmcl.2015.07.032","article-title":"Interfacial inhibitors","volume":"25","author":"Pommier","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.04.033_bib9b","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/1568011043352777","article-title":"Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints","volume":"4","author":"Pommier","year":"2004","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.ejmech.2018.04.033_bib11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1124\/mol.106.024372","article-title":"Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis (trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity","volume":"70","author":"Antony","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.033_bib12a","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.bcp.2013.02.024","article-title":"Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect","volume":"85","author":"Prada","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.033_bib12b","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1128\/AAC.00499-12","article-title":"Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis","volume":"56","author":"Bala\u00f1a-Fouce","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.04.033_bib12c","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.drudis.2006.06.014","article-title":"Targeting atypical trypanosomatid DNA topoisomerase I","volume":"11","author":"Bala\u00f1a-Fouce","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2018.04.033_bib12d","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbaexp.2006.03.006","article-title":"DNA topoisomerase I from parasitic protozoa: a potential target for chemotherapy","volume":"1759","author":"Reguera","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2018.04.033_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003666","article-title":"Infrared fluorescent imaging as a potent tool for in\u00a0vitro, ex\u00a0vivo and in\u00a0vivo models of visceral leishmaniasis","volume":"9","author":"Calvo-\u00c1lvarez","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2018.04.033_bib14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejmech.2016.09.017","article-title":"Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase","volume":"124","author":"Tejer\u00eda","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib15","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals","volume":"57","author":"Vitaku","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib16a","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1021\/cr400552x","article-title":"Fruitful decade for antileishmanial compounds from 2002 to late 2011","volume":"114","author":"Hussain","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.04.033_bib16b","doi-asserted-by":"crossref","first-page":"32376","DOI":"10.1039\/C5RA02669E","article-title":"Antileishmanial drug discovery: comprehensive review of the last 10 years","volume":"5","author":"Sangshetti","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.04.033_bib17","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.2174\/1568026614666141215152441","article-title":"Synthesis and biological evaluation of 1,5-naphthyridines as topoisomerase I inhibitors. A new family of antiproliferative agents","volume":"14","author":"Alonso","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib18a","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1021\/acs.joc.6b02034","article-title":"The modern face of synthetic heterocyclic chemistry","volume":"81","author":"Cabrele","year":"2016","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib18b","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.2174\/138527212802651322","article-title":"New approaches to nitrogen containing heterocycles: enantioselective organocatalyzed synthesis of dihydropyridines (DHP's), quinolizidine derivatives and dihydropyrimidines (DHPM's)","volume":"16","author":"Thu Pham","year":"2012","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib18c","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1016\/j.bmc.2012.05.035","article-title":"Synthesis of 6-substituted 9-methoxy-11H-indeno[1,2-c] quinoline-11-one derivatives as potential anticancer agents","volume":"20","author":"Tseng","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib18d","first-page":"190","article-title":"Synthesis and biological evaluation of some nitrogen containing heterocycles","volume":"9","author":"Abdel-Ghaffar","year":"2011","journal-title":"Nat. Sci."},{"key":"10.1016\/j.ejmech.2018.04.033_bib18e","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1126\/science.287.5460.1964","article-title":"Target-oriented and diversity-oriented organic synthesis in drug discovery","volume":"287","author":"Schreiber","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.04.033_bib19","series-title":"Name Reactions for Carbocyclic Ring Formations","first-page":"275","author":"Shea","year":"2010"},{"key":"10.1016\/j.ejmech.2018.04.033_bib20a","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/adsc.200600431","article-title":"Conceptual, qualitative, and quantitative theories of 1,3-dipolar and diels\u2013alder cycloadditions used in synthesis","volume":"348","author":"Ess","year":"2006","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2018.04.033_bib20b","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO;2-Z","article-title":"The diels\u2013alder reaction in total synthesis","volume":"41","author":"Nicolaou","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2018.04.033_bib20c","series-title":"The Diels\u2013Alder Reaction: Selected Practical Methods","author":"Fringuelli","year":"2002"},{"key":"10.1016\/j.ejmech.2018.04.033_bib21a","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1039\/C6GC02334G","article-title":"Improving the efficiency of the Diels\u2013Alder process by using flow chemistry and zeolite catalysis","volume":"19","author":"Seghers","year":"2017","journal-title":"Green Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib21b","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1002\/anie.201201636","article-title":"Industrial applications of the Diels\u2013alder reaction","volume":"52","author":"Funel","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2018.04.033_bib21c","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1016\/j.tetlet.2010.08.117","article-title":"Straightforward hetero Diels\u2013Alder reactions of nitroso dienophiles by microreactor technology","volume":"51","author":"Monbaliu","year":"2010","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.04.033_sref13","unstructured":"(For reviews see: )"},{"key":"10.1016\/j.ejmech.2018.04.033_bib22a","first-page":"157","volume":"13","author":"Bello","year":"2016","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib22b","first-page":"303","article-title":"Multicomponent reactions","volume":"vols. 1 and 2","author":"Voskressensky","year":"2014"},{"key":"10.1016\/j.ejmech.2018.04.033_bib22c","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1039\/C2CS35370A","volume":"42","author":"Masson","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2018.04.033_bib22d","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1021\/cr300436a","volume":"113","author":"Jiang","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.04.033_bib22e","first-page":"2237","article-title":"New heterocyclic inputs for the Povarov multicomponent reaction","author":"Vicente-Garcia","year":"2011","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2018.04.033_bib22f","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.tet.2008.12.059","article-title":"Recent synthetic developments in a powerful imino Diels\u2013Alder reaction (Povarov reaction): application to the synthesis of N-polyheterocycles and related alkaloids","volume":"65","author":"Kouznetsov","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.04.033_bib22g","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1070\/RC1967v036n09ABEH001680","article-title":"\u03b1,\u03b2-Unsaturated ethers and their analogues in reactions of diene synthesis","volume":"36","author":"Povarov","year":"1967","journal-title":"Russ. Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.04.033_sref14","unstructured":"(For recent contributions see: )"},{"key":"10.1016\/j.ejmech.2018.04.033_bib23a","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1021\/acs.joc.7b00838","article-title":"Photochemically promoted aza-Diels-Alder-type reaction: high catalytic activity of the Cr(III)\/Bipyridine complex enhanced by visible light irradiation","volume":"82","author":"Arai","year":"2017","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib23b","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1021\/acs.orglett.7b01686","article-title":"Synergistic I2\/Amine promoted Povarov-type reaction for the synthesis of 2-Acyl-3-aryl(alkyl)quinolines using aryl(alkyl)acetaldehydes as alkene surrogates","volume":"19","author":"Geng","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.04.033_bib23c","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.bmcl.2017.02.077","article-title":"Srivari Expanding the tetrahydroquinoline pharmacophore","volume":"27","author":"Goli","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.04.033_bib23d","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1002\/anie.201705746","article-title":"Enantioselective organocatalytic intramolecular aza-Diels-Alder reaction","volume":"56","author":"Jarrige","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2018.04.033_bib23e","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1021\/acs.orglett.6b03330","article-title":"Step-controlled povarov-type reaction with 1,2-dihydroquinolines as precursors of dienophiles: direct synthesis of spirocyclic Bi-tetrahydroquinolines and functionalized 1,2-dihydroquinolines","volume":"19","author":"Ren","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.04.033_bib24a","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/acs.orglett.7b03395","article-title":"Combining visible-light-photoredox and lewis acid catalysis for the synthesis of indolizino[1,2-b]quinolin-9(11H)-ones and irinotecan precursor","volume":"20","author":"Dong","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.04.033_bib24b","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ejmech.2017.07.027","article-title":"Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues","volume":"138","author":"Almansour","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib24c","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1021\/acs.orglett.6b01065","article-title":"Ming copper-catalyzed aza-Diels-Alder reaction and halogenation: an approach to synthesize 7-halogenated chromenoquinolines","volume":"18","author":"Yu","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.04.033_bib24d","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.tet.2006.02.029","article-title":"Synthesis of the heterocyclic core of martinelline and martinellic acid","volume":"62","author":"Hadden","year":"2006","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.04.033_bib24e","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1021\/ol0479848","article-title":"Intramolecular hetero Diels\u2212Alder (Povarov) approach to the synthesis of the alkaloids luotonin a and camptothecin","volume":"6","author":"Twin","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.04.033_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2016.03.031","article-title":"Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity","volume":"115","author":"Alonso","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib26","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1002\/ejoc.201100395","article-title":"Glyoxalate-derived aldimines in cycloaddition reactions with olefins","author":"Palacios","year":"2011","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib27","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1021\/acs.joc.7b00977","article-title":"Study of the hetero-[4+2]-cycloaddition reaction of aldimines and alkynes. Synthesis of 1,5-naphthyridine and isoindolone derivatives","volume":"82","author":"Alonso","year":"2017","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.033_bib28","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/cr500368h","article-title":"Carbon trifluoromethylation reactions of hydrocarbon derivatives and heteroarenes","volume":"115","author":"Fluorine substituents are important fragments of commercial drugs","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.04.033_bib29","article-title":"Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex\u00a0vivo splenic explant model system","volume":"5","author":"Osorio","year":"2001","journal-title":"PLoS Neglected Trop. Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T19:03:26Z","timestamp":1751569406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418303672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":73,"alternative-id":["S0223523418303672"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.033","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}